Mirtazapine 7.5 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Mirtazapine 7.5 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Tetracyclic Antidepressant (NaSSA)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Mirtazapine 7.5 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Mirtazapine 7.5 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Mirtazapine 7.5 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Mirtazapine 7.5 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Depression with insomnia
- Depression with anorexia / weight loss
- Palliative care (appetite + sleep)
- Cancer-related anorexia (off-label)
Mechanism of Action
Mirtazapine is a NaSSA (Noradrenergic and Specific Serotonergic Antidepressant) — antagonises alpha-2 adrenoceptors increasing NE and 5-HT release, while blocking 5-HT2 and 5-HT3 receptors. Strong H1 antagonism causes sedation and appetite stimulation at low doses.
Dosage & Administration
- Adults: 7.5 mg at bedtime, may increase to 15–45 mg.
Side Effects
- Sedation (paradoxically less at higher doses), weight gain, dry mouth, constipation, rare neutropenia.
Contraindications
- Hypersensitivity, MAOI use within 14 days, severe hepatic impairment.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Mirtazapine 7.5 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Mirtazapine 7.5 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Mirtazapine 7.5 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Mirtazapine 7.5 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Mirtazapine 7.5 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Mirtazapine 7.5 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Mirtazapine 7.5 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Mirtazapine 7.5 mg Tablet?
Available pack sizes include: 10 x 10 (Blister).
What is the MRP / trade price for Mirtazapine 7.5 mg Tablet?
MRPs range from ₹770 to ₹770 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Mirtazapine 7.5 mg Tablet?